BioAge Labs, Inc. (BIOA)
9.65
-0.43
(-4.27%)
USD |
NASDAQ |
Aug 28, 16:00
9.65
0.00 (0.00%)
After-Hours: 20:00
BioAge Labs Price to Book Value : 1.178 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.178 |
| August 27, 2026 | 1.231 |
| August 26, 2026 | 1.202 |
| August 25, 2026 | 1.234 |
| August 24, 2026 | 1.145 |
| August 21, 2026 | 1.158 |
| August 20, 2026 | 1.183 |
| August 19, 2026 | 1.313 |
| August 18, 2026 | 1.277 |
| August 17, 2026 | 1.270 |
| August 14, 2026 | 1.294 |
| August 13, 2026 | 1.274 |
| August 12, 2026 | 1.280 |
| August 11, 2026 | 1.303 |
| August 10, 2026 | 1.398 |
| August 07, 2026 | 1.431 |
| August 06, 2026 | 1.376 |
| August 05, 2026 | 1.341 |
| August 04, 2026 | 1.368 |
| August 03, 2026 | 1.316 |
| July 31, 2026 | 1.104 |
| July 30, 2026 | 3.034 |
| July 29, 2026 | 2.709 |
| July 28, 2026 | 2.676 |
| July 27, 2026 | 2.550 |
| Date | Value |
|---|---|
| July 24, 2026 | 2.658 |
| July 23, 2026 | 2.674 |
| July 22, 2026 | 2.679 |
| July 21, 2026 | 2.766 |
| July 20, 2026 | 2.725 |
| July 17, 2026 | 2.785 |
| July 16, 2026 | 2.706 |
| July 15, 2026 | 2.772 |
| July 14, 2026 | 2.781 |
| July 13, 2026 | 2.66 |
| July 10, 2026 | 2.972 |
| July 09, 2026 | 3.039 |
| July 08, 2026 | 2.885 |
| July 07, 2026 | 2.979 |
| July 06, 2026 | 3.033 |
| July 02, 2026 | 3.065 |
| July 01, 2026 | 2.962 |
| June 30, 2026 | 2.993 |
| June 29, 2026 | 2.921 |
| June 26, 2026 | 2.782 |
| June 25, 2026 | 2.648 |
| June 24, 2026 | 2.673 |
| June 23, 2026 | 2.613 |
| June 22, 2026 | 2.514 |
| June 18, 2026 | 2.432 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 32.64 |
| Pfizer Inc. | 1.870 |
| Oramed Pharmaceuticals, Inc. | 0.6546 |
| Liquidia Corp. | 30.91 |
| Neumora Therapeutics, Inc. | 5.834 |
Price to Book Value Related Metrics
| PS Ratio | 37.11 |
| PEG Ratio | -0.5991 |
| Price | 9.65 |
| Earnings Yield | -24.73% |
| Market Cap | 441.75M |
| PEGY Ratio | -0.5991 |